These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3495509)

  • 1. Hypoxia-selective radiosensitization of mammalian cells by nitracrine, an electron-affinic DNA intercalator.
    Roberts PB; Anderson RF; Wilson WR
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Apr; 51(4):641-54. PubMed ID: 3495509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
    Wilson WR; Siim BG; Denny WA; van Zijl PL; Taylor ML; Chambers DM; Roberts PB
    Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitization of mammalian cells in vitro by nitroacridines.
    Roberts PB; Denny WA; Wakelin LP; Anderson RF; Wilson WR
    Radiat Res; 1990 Aug; 123(2):153-64. PubMed ID: 2389001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the radiosensitization potency afforded by nitroacridine intercalators with their electron scavenging efficiency in DNA.
    Anderson RF; Denny WA; Roberts PB; Wardman P; White J; Wilson WR
    Int J Radiat Oncol Biol Phys; 1992; 22(3):537-40. PubMed ID: 1735692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reaction between nitracrine and glutathione: implications for hypoxic cell radiosensitization and cytotoxicity.
    Wilson WR; Anderson RF
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1001-5. PubMed ID: 2703377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism.
    Siim BG; Hicks KO; Pullen SM; van Zijl PL; Denny WA; Wilson WR
    Biochem Pharmacol; 2000 Oct; 60(7):969-78. PubMed ID: 10974206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
    Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD
    Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductive metabolism and hypoxia-selective toxicity of nitracrine.
    Wilson WR; Denny WA; Stewart GM; Fenn A; Probert JC
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1235-8. PubMed ID: 3744944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective toxicity of nitracrine to hypoxic mammalian cells.
    Wilson WR; Denny WA; Twigden SJ; Baguley BC; Probert JC
    Br J Cancer; 1984 Feb; 49(2):215-23. PubMed ID: 6696822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.
    Wilson WR; Thompson LH; Anderson RF; Denny WA
    J Med Chem; 1989 Jan; 32(1):31-8. PubMed ID: 2909741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide.
    Wilson WR; Van Zijl P; Denny WA
    Int J Radiat Oncol Biol Phys; 1992; 22(4):693-6. PubMed ID: 1544839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine.
    Wilson WR; Anderson RF; Denny WA
    J Med Chem; 1989 Jan; 32(1):23-30. PubMed ID: 2909736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
    Denny WA; Roberts PB; Anderson RF; Brown JM; Phil D; Wilson WR
    Int J Radiat Oncol Biol Phys; 1992; 22(3):553-6. PubMed ID: 1735695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
    J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation.
    Cowan DS; Kanagasabapathy VM; McClelland RA; Rauth AM
    Int J Radiat Oncol Biol Phys; 1992; 22(3):541-4. PubMed ID: 1735693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization by nickel lapachol.
    Skov KA; Adomat H; Farrell NP
    Int J Radiat Biol; 1993 Dec; 64(6):707-13. PubMed ID: 7903338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitizers as probes of DNA damage and cell killing.
    Greenstock CL; Whitehouse RP
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Nov; 48(5):701-10. PubMed ID: 3877011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and radiosensitization of 4,5-dimethylmisonidazole, a ring-substituted analog of misonidazole.
    Born JL; Smith BR; Harper N; Koch CJ
    Biochem Pharmacol; 1992 Mar; 43(6):1337-44. PubMed ID: 1562284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM; Yu NY; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds.
    Papadopoulou MV; Epperly MW; Shields DS; Bloomer WD
    Jpn J Cancer Res; 1992 Apr; 83(4):410-4. PubMed ID: 1506276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.